An Observational Study of Avastin (Bevacizumab) in Combination With Carboplatin/Paclitaxel in First Line in Patients With Advanced Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (OTILIA)

NCT01697488 · clinicaltrials.gov ↗
COMPLETED
Status
1090
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Hoffmann-La Roche